Shandong Weigao Group Medical Polymer has secured approval from the Hong Kong Stock Exchange to convert 48,300,000 unlisted shares into H shares. This move, announced on 20 November 2026, will effectively bring the company's H-share float to 100% by eliminating all remaining unlisted shares.
On 18 November 2026 the Stock Exchange approved listing of 48,300,000 H Shares held by nine shareholders, equal to about 1.06% of the 4,570,632,324 total issued shares. Conversion removes the last unlisted shares and slightly enlarges the H-share free float, which could add minor selling pressure but is small relative to the 4,522,332,324 already-listed H Shares. Completion remains subject to further regulatory procedures, so the near-term price effect is limited.
- • Exchange approval received 18 November 2026 for conversion and listing of 48,300,000 H Shares
- • Unlisted shares fall from 1.06% to 0.00% of issued shares, raising H-share float to 100%
- • Conversion still subject to other procedures required by the Stock Exchange and domestic and overseas regulators
- • Up to 1.06% of new tradable shares may create modest overhang if the participating shareholders sell